Dr. Matthew Pozzebon is a Clifton, New Jersey based male chiropractor who is specialized as General Chiropractor. Active license number of Dr. Matthew Pozzebon as General Chiropractor is 38MC00701000 in New Jersey. Dr. Matthew Pozzebon is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Matthew Pozzebon speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
D.C.
Gender:
Male
Practice Address:
1117 Route 46 Ste 204, Clifton, New Jersey, 07013-2450
Phone:
562-587-6352
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1013267186
NPI Enumeration Date:
14 Sep, 2012
NPI Last Update On:
25 Apr, 2019
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Matthew Pozzebon are as mentioned below.
License Number
Specialization
State
Status
38MC00701000
Chiropractor
New Jersey
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
115 Lake St, Englewood, New Jersey
Zip:
07631-4923
Phone Number:
562-587-6352
Fax Number:
--
Patients can reach Dr. Matthew Pozzebon at 1117 Route 46 Ste 204, Clifton, New Jersey or can call to book an appointment on 562-587-6352. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.